{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260504944663/en/Takeda-Announces-Positive-Topline-Results-from-Pivotal-Phase-23-Clinical-Trial-of-TAK-881-in-Primary-Immunodeficiency-Disease-PID", "message": "News view counter 699726 successfully enlarged"}